Low exposition to lithium prevents nephrogenic diabetes insipidus but not microcystic dilations of the collecting ducts in long‐term rat model
Open Access
- 5 May 2024
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 357 (8) , e2400063
Abstract
Lithium induces nephrogenic diabetes insipidus (NDI) and microcystic chronic kidney disease (CKD). As previous clinical studies suggest that NDI is dose‐dependent and CKD is time‐dependent, we investigated the effect of low exposition to lithium in a long‐term experimental rat model. Rats were fed with a normal diet (control group), with the addition of lithium (Li+ group), or with lithium and amiloride (Li+/Ami group) for 6 months, allowing obtaining low plasma lithium concentrations (0.25 ± 0.06 and 0.43 ± 0.16 mmol/L, respectively). Exposition to low concentrations of plasma lithium levels prevented NDI but not microcystic dilations of kidney tubules, which were identified as collecting ducts (CDs) on immunofluorescent staining. Both hypertrophy, characterized by an increase in the ratio of nuclei per tubular area, and microcystic dilations were observed. The ratio between principal cells and intercalated cells was higher in microcystic than in hypertrophied tubules. There was no correlation between AQP2 messenger RNA levels and cellular remodeling of the CD. Additional amiloride treatment in the Li+/Ami group did not allow consistent morphometric and cellular composition changes compared to the Li+ group. Low exposition to lithium prevented overt NDI but not microcystic dilations of the CD, with differential cellular composition in hypertrophied and microcystic CDs, suggesting different underlying cellular mechanisms.Keywords
Funding Information
- Agence Nationale de la Recherche
This publication has 45 references indexed in Scilit:
- Chronic Lithium Therapy and Urine-Concentrating Ability in Individuals With Bipolar Disorder: Association Between Daily Dose and Resistance to Vasopressin and PolyuriaKidney International Reports, 2022
- Complications métaboliques et rénales chroniques du traitement par sels de lithiumLa Revue de Médecine Interne, 2019
- RNA-Seq and protein mass spectrometry in microdissected kidney tubules reveal signaling processes initiating lithium-induced nephrogenic diabetes insipidusKidney International, 2019
- Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory dataThe Lancet, 2015
- Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysisThe Lancet Psychiatry, 2014
- Lithium toxicity profile: a systematic review and meta-analysisThe Lancet, 2012
- Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trialThe Lancet, 2010
- Lithium-induced uremia in rats ? a new model of chronic renal failurePflügers Archiv - European Journal of Physiology, 1983
- Stimulation of proximal tubular sodium reabsorption by ile5 angiotensin II in the rat kidneyPflügers Archiv - European Journal of Physiology, 1979
- Chronic renal lesions following long-term treatment with lithiumKidney International, 1977